Cost-Benefit Analysis Of GeneXpert MTB/RIF For Evaluation Of Infectious Tuberculosis At An Urban Public Hospital
Millman A, Dowdy D, Brownell R, Cattamanchi A, Davis J. Cost-Benefit Analysis Of GeneXpert MTB/RIF For Evaluation Of Infectious Tuberculosis At An Urban Public Hospital. 2012, a6505-a6505. DOI: 10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6505.Peer-Reviewed Original ResearchGeneXpert MTB/RIFMTB/RIFUrban public hospitalInfectious tuberculosisPublic hospitalsHospitalTuberculosis